JEFFREY RILEY

Profile

First Name

: JEFFREY

Middle Name

:

Last Name

: RILEY

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

SYNTHETIC BIOLOGICS, INC.

C. EVAN BALLANTYNE, STEVE KANZER, STEVE H. KANZER, JEFFREY KRAWS, JEFFREY J. KRAWS, JOHN MONAHAN, STEVEN SHALLCROSS, STEVEN A SHALLCROSS, STEVEN A. SHALLCROSS, JOSEPH SLIMAN, SCOTT TARRIFF, SCOTT L. TARRIFF, JEFFREY WOLF, JEFFREY A. WOLF

DIRECTOR

PERLE BIOSCIENCE, INC.

DOUGLAS CARNES, RYAN N. FIORINI, DONNA HILL, CLARESA LEVETAN, GILBERT NATHAN, LLOYD A. PEARSON

DIRECTOR

GAIN THERAPEUTICS, INC.

MARIANNE BJORDAL, KHALID ISLAM, LORENZO LEONI, ERIC I. RICHMAN

EXECUTIVE OFFICER, DIRECTOR

ROBERT E. BRANAN, DOUGLAS M. CARNES, ROBERT DICKEY, RYAN N. FIORINI, PETER KECK, ROBERT E. KENNEDY, CYNTHIA MARSHALL, JACKIE MCKELVEY, STEVE MCMANUS, KATHY PHLEGAR, HARVEY SCHILLER, NELSON K. STACKS, AQUILLA S. TURK

EXECUTIVE OFFICER, DIRECTOR

CARAVAN BIOLOGIX, INC.

LLEW KELTNER, THOMAS MALCOLM, MICHAEL MARTINO, DAVID ROWE

DIRECTOR

GALENA INNOVATIONS, INC.

ASHLEY CRAFTON, LAWRENCE WASDEN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

2024-07-10

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-03-07

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Debt

2021-09-15

D/A

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-01-15

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-07-20

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2017-09-11

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2015-11-24

D

OTHER

DECLINE TO DISCLOSE

Equity

2015-11-24

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2012-10-30

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2012-10-16